Trials / Unknown
UnknownNCT05902884
New Biomarkers in Facioscapulohumeral Muscular Dystrophy, Multispectral Optoacoustic Tomography.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Facioscapulohumeral Muscular Dystrophy (FSHD) is one of the most frequent muscular dystrophies in the adulthood. Multi-spectral optoacoustic tomography (MSOT) is an innovative imaging technique able to non-invasively characterize the molecular composition of the muscle tissue. With this pilot study we will explore the performance of MSOT imaging in FSHD patients and correlate the findings with clinical and MRI data, with the final aim to identify new disease biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MSOT Acuity Echo | Imaging of muscles applying Multi-spectral optoacoustic tomography (MSOT) |
Timeline
- Start date
- 2023-06-26
- Primary completion
- 2023-09-30
- Completion
- 2023-12-30
- First posted
- 2023-06-15
- Last updated
- 2023-07-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05902884. Inclusion in this directory is not an endorsement.